Feature Channels:

Transplantation

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Bortezomib, Kidney Transplant

Clinical Trial Does Not Support the Use of Bortezomib for Kidney Transplant Recipients

• In a trial of kidney transplant recipients with late antibody-mediated rejection, treatment with bortezomib, a type of proteasome inhibitor, failed to improve the function of transplanted kidneys and prevent immunologic tissue injury. • Bortezomib treatment was also linked with gastrointestinal and hematologic toxicity.

Medicine

Channels:

ASN Partners with VA Center for Innovation on My Kidney Nutrition App Features CHALLENGEWashington, DC (December 12, 2017) — Around 17% of American Adults Have Chronic Kidney Disease (CKD), and the Rate of Prevalence Is Higher for US Veterans. CKD,

Around 17% of American adults have chronic kidney disease (CKD), and the rate of prevalence is higher for US Veterans. CKD, if not treated appropriately, can ultimately lead to kidney failure requiring either dialysis or a transplant.

Medicine

Channels:

Disparities, Stem Cell Therapy, Multiple Myeloma

Study Identifies Barriers to Transplant Therapy to Treat Multiple Myeloma Among Racial Minority Groups

A study by researchers at Mayo Clinic’s campus in Jacksonville, Florida has found that barriers to patients receiving stem cell therapy as part of their treatment for multiple myeloma include income, education, insurance status and access to care at an academic center or facility that treats a high volume of patients.

Medicine

Channels:

Heart Transplant, NYU Langone Health, Heart Failure, Transplant Institute

New Heart Transplant Program Launched at NYU Langone Health

nader-moazami-hero-crop.jpg

NYU Langone launches a new heart transplant program.

Science

Channels:

multiple myelmoma, Cancer, Hematologic Cancers

Study Explores Use of Checkpoint Inhibitors After Relapse From Donor Stem Cell Transplant for Hematologic Cancers

Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after a transplant with donor stem cells. Preliminary results from the first clinical trial in these patients of one such agent – nivolumab – indicate that along with signs of effectiveness, it also produced significant side effects at the dose initially studied. The findings indicate a need for further clinical trials in this group before being considered for off-label use with these patients, Dana-Farber Cancer Institute investigators report.

Medicine

Channels:

Cancer, Hematology, stem cell tranplantation, Graft Versus Host Disease, Immunotherapy

Immunotherapy Drug for Rheumatoid Arthritis Nearly Eliminates Severe Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplant

Kean_Leslie_ep_636167.jpg

Results from a phase 2 clinical trial, presented by Seattle Children’s Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft-versus-host disease (GvHD) in patients receiving hematopoietic stem cell transplants.

Medicine

Channels:

Kidney Transplant, Kidney, Kidney Advocacy, Liver Transplant, Kidney Transplantation, Kidney Transplants, Nephrotic Syndrome, Diabetes, High Blood Pressure, deceased donor, deceased donor liver transplant, Living Donor Kidney Transplant, Living Donor

Two Alabamians Push UAB Hospital Past Milestone of 10,000 Kidney Transplants

michaelcox-1.jpg

The hope given from a deceased donor, and a sibling, give two kidney transplant recipients a chance to live

Medicine

Channels:

kidney discard, Transplantation

Many Donor Kidneys that Are Discarded May Be Suitable for Transplantation

• In an analysis of pairs of kidneys from the same donor in which 1 kidney was used but the other was discarded, the kidneys that were used tended to perform well. • The majority of discarded kidneys could have potentially been transplanted with good outcomes.

Medicine

Channels:

Children's Hospital Los Angeles, Leukemia, Stem Cell Transplant, Donor, Acute Myeloid Leukemia, be the match, National Marrow Donor Program, Chemotherapy, Stem Cells, Cancer

#FiercePierce: 2-Year-Old Patient Beats Back Leukemia and Inspires Thousands of Potential Stem Cell Donors

FiercePierce.jpg

2-year-old Children's Hospital Los Angeles patient Pierce Kelly beats leukemia thanks to a stem cell donor in France and inspires thousands of potential donors.

Medicine

Science

Channels:

Researchers 3D Print Lifelike Artificial Organ Models

A team of researchers led by the University of Minnesota has 3D printed lifelike artificial organ models that mimic the exact anatomical structure, mechanical properties, and look and feel of real organs. These patient-specific organ models, which include integrated soft sensors, can be used for practice surgeries to improve surgical outcomes in thousands of patients worldwide.







Chat now!